Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 11:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1009–1032 of 121,433 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Plaque Psoriasis
Interventions: LCD Solution with NB-UVB Phototherapy, NB-UVB Light Device (311-315 nm); Other · Device
Lead sponsor: NeoStrata Company, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: East Windsor, New Jersey

Conditions: Uterine Fibroids, Heavy Menstrual Bleeding
Interventions: OBE2109, Placebo to match OBE2109, Placebo to match Add-back, Add-back; Drug
Lead sponsor: ObsEva SA; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 511 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 23
States / cities: Chino, California • Huntington Park, California • San Diego, California + 19 more

Conditions: Morbid Obesity, Cesarean Section Complications, Pregnancy Related
Interventions: Retrospective chart review; Other
Lead sponsor: Augusta University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 771 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage I Cervical Cancer AJCC v6 and v7, Stage IA Cervical Cancer AJCC v6 and v7, Stage IB Cervical Cancer AJCC v6 and v7, Stage IIA Cervical Cancer AJCC v7
Interventions: Cisplatin, External Beam Radiation Therapy, Intensity-Modulated Radiation Therapy, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration; Drug · Radiation · Other
Lead sponsor: GOG Foundation; Network
Eligibility: 18 Years and older · Female only
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2024
U.S. locations: 698
States / cities: Anchorage, Alaska • Fairbanks, Alaska • Phoenix, Arizona + 433 more

Conditions: COVID-19
Interventions: S-892216, Placebo; Drug
Lead sponsor: Shionogi; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 21
States / cities: Hot Springs, Arkansas • Coconut Creek, Florida • Coral Gables, Florida + 11 more

Conditions: Diabetes Mellitus, Type 2, Diabetes Complications
Interventions: Diabetes Tune-Up Group; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 21 Years and older · Female only
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Chemotherapy Induced Peripheral Neuropathy, Cancer
Interventions: sensor-based interactive exercise (game-based exercise), Intervention without game-based exercise; Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 55 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Pain, Postoperative, Tooth Diseases
Interventions: ibuprofen + caffeine, ibuprofen, caffeine, placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 562 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Heart Failure
Interventions: Medically Tailored Meal Program with Traditional Navajo Foods; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Tohatchi, New Mexico

Conditions: Pulmonary Arterial Hypertension
Interventions: sapropterin dihydrochloride (6R-BH4); Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Ischemic Stroke, Hemorrhagic Stroke, Traumatic Brain Injury
Interventions: Lateral Flow Device; Device
Lead sponsor: Justin Fraser; Other
Eligibility: 21 Years to 85 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: HIV Infections
Interventions: Not listed
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 21 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2004
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Bullous Pemphigoid
Interventions: dupilumab, Matching Placebo, Oral corticosteroids (OCS); Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 15
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Redwood City, California + 12 more

Conditions: Parkinson Disease, Autonomic Nervous System Diseases, Pure Autonomic Failure
Interventions: 6-[18F]Fluorodopamine, 6-[18F]Fluorodopa, 13N-Ammonia; Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2023
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hiv, Tobacco Smoking
Interventions: TBS, Sham TMS; Device
Lead sponsor: Gopalkumar Rakesh; Other
Eligibility: 18 Years to 60 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Lexington, Kentucky

Conditions: Type 1 Diabetes
Interventions: DailyDose Decision Support; Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Heart Failure With Preserved Ejection Fraction (HFpEF)
Interventions: AZD4831, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Glendale, California

Conditions: Weight Regain, Weight Recidivism, Obesity Recidivism, Clinically Severe Obesity
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 65 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Fresno, California

Conditions: Alcohol Use Disorder
Interventions: High-Intensity Cue, Low-Intensity Cue; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Weight Loss
Interventions: Second Life, Group Phone Conference Call; Other · Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 21 Years to 65 Years
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Obesity, Asthma
Interventions: Not listed
Lead sponsor: National Jewish Health; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Mechanical Ventilation Complication
Interventions: intermittent IV CLON; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 1 Day to 12 Months
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Rectal Hyposensitivity, Constipation
Interventions: Syringe Conditioning, Barostat Conditioning; Procedure
Lead sponsor: Augusta University; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Becker Muscular Dystrophy
Interventions: Sodium Nitrate, Sodium Nitrate - double dose, Placebo, Increased exercise intensity; Dietary Supplement · Procedure
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 15 Years to 45 Years · Male only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

NB-UVB Phototherapy With and Without Topical LCD Treatment: a Bilateral Pilot Study

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Anesthetic and Obstetric Outcomes in Morbidly Obese Pregnancy and Cesarean Delivery

Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

A Study of S-892216 in Participants With COVID-19

Electronic Diabetes Tune-Up Group (eDTU) for African Americans

Using Game-based Exercise to Improve Balance in Cancer Patients

Efficacy and Safety of Ibuprofen and Caffeine in Dental Pain

Mutton Heart Failure Food is Medicine Pilot

6R-BH4 Pulmonary Arterial Hypertension Study

Stroke and Traumatic Acute Brain Injury Line Indicator System for Emergent Recognition (STABILISER-I)

Spirituality and Will to Live in Patients With HIV/AIDS

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid

Biomarkers of Risk of Parkinson Disease

Accelerated Transcranial Magnetic Stimulation (TMS) for Smoking Cessation in People Living With HIV/AIDS (PLWHA)

Assessment of a Decision Support Tool in Participants With Type 1 Diabetes

A Study to Assess the Effect AZD4831 in Japanese and Chinese Healthy Volunteers

Laparoscopic Revision Gastric Bypass for Weight Recidivism

Enhancing Prospective Thinking in Early Recovery (BEAM)

A Virtual Reality Intervention to Improve Weight Maintenance

The Effect of Obesity on Lung Functioning

Intravenous Clonidine for Sedation in Infants and Children Who Are Mechanically Ventilated - Dosing Finding Study

Rectal Sensory Training - A Study of Two Techniques

Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy